#LCSM Chat Topic 6-May-2021: The Hows and Whys of Cancer Research Advocacy

Cancer patient advocates first appeared decades ago, in the breast cancer community.  Patient advocates are dedicated to supporting patients and their loved ones, improving lung cancer education and awareness, and generating funds for advocacy and research.  With the advent of targeted therapies and immunotherapies for many types of cancer, the past ten years have seen a growing group of patients, survivors, and caregivers who have lived with cancer long enough to become active, knowledgeable advocates for their cancer community. There is another type of cancer patient advocate called a “research advocate.” Research… Read More

#LCSM Chat topic 3-Oct-2019: The Path to Research Advocacy

Please join the #LCSM community and moderator Janet Freeman-Daily (@JFreemanDaily) for our next #LCSM Chat on Thursday, October 3, 2019, at 8 pm Eastern Time (5 pm Pacific) to discuss “The Path to Research Advocacy.” Cancer patients and their loved ones who have the skills, interest, and energy may become patient advocates for their disease. Their activities might include providing support and resources to other patients, acting as liaisons between patients and clinicians, raising awareness and educating others about their disease, and engaging in fundraising activities for advocacy and research. Some patient… Read More

#LCSM Chat Topic 03/07: Biomarker Magicians (or, Why We Love Pathologists)

Diagnosing the type of lung cancer from a tissue or liquid biopsy is absolutely critical to selecting treatment and determining the patient’s prognosis. However, for many lung cancer patients and their families, the role of tumor tissue in their diagnosis is a mystery. What happens to tissue collected in a biopsy? How is it analyzed? What is involved in getting helpful answers from biomarker testing? The specialized doctors responsible for answering these questions are pathologists.  They identify any lung cancer cells in the biopsied tissue, and guide the patient’s biomarker testing. Unfortunately,… Read More